MSI Financial Services’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$61K Sell
3,616
-2,134
-37% -$37.5K ﹤0.01% 1754
2016
Q3
$108K Sell
5,750
-3,173
-36% -$59.8K ﹤0.01% 1362
2016
Q2
$153K Sell
8,923
-4,881
-35% -$90.1K 0.01% 1164
2016
Q1
$248K Buy
13,804
+5,275
+62% +$95.8K 0.01% 879
2015
Q4
$202K Buy
8,529
+7,571
+790% +$188K 0.01% 942
2015
Q3
$22K Buy
958
+18
+2% +$504 ﹤0.01% 1660
2015
Q2
$27K Sell
940
-519
-36% -$14.4K ﹤0.01% 1645
2015
Q1
$40K Sell
1,459
-7
-0.5% -$191 ﹤0.01% 1424
2014
Q4
$36K Buy
1,466
+35
+2% +$840 ﹤0.01% 1224
2014
Q3
$32K Buy
1,431
+247
+21% +$5.37K ﹤0.01% 1281
2014
Q2
$25K Buy
1,184
+517
+78% +$10.9K ﹤0.01% 1393
2014
Q1
$15K Buy
667
+10
+2% +$223 ﹤0.01% 1553
2013
Q4
$13K Buy
657
+9
+1% +$175 ﹤0.01% 1575
2013
Q3
$12K Buy
648
+559
+628% +$10.7K ﹤0.01% 1375
2013
Q2
$2K Buy
+89
New +$1.61K ﹤0.01% 2105

Other funds holding HQL

MSI Financial Services's HQL Position: Q4 2016 in Review

MSI Financial Services reduced its abrdn Life Sciences Investors (HQL) stake by 37% in Q4 2016, selling an estimated $37.5K and leaving 3,616 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #1754.

MSI Financial Services first reported a position in HQL in Q2 2013 and has held it in 15 quarters since. The position peaked at $248K in Q1 2016. 49 funds tracked by Wall St. Rank hold HQL as of Q4 2016.

  • MSI Financial Services held 3,616 shares of abrdn Life Sciences Investors worth $61K as of Q4 2016.
  • MSI Financial Services sold 2,134 abrdn Life Sciences Investors shares in Q4 2016, an estimated $37.5K.
  • abrdn Life Sciences Investors made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #1754 holding.
  • MSI Financial Services first reported a position in abrdn Life Sciences Investors in Q2 2013 and has held it in 15 quarters since.
  • MSI Financial Services's abrdn Life Sciences Investors position peaked at $248K in Q1 2016.
  • 49 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.